Creo Medical Group (LON:CREO) Reaches New 12-Month Low – Time to Sell?

Creo Medical Group PLC (LON:CREO) shares reached a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 11.80 ($0.15) and last traded at GBX 12.31 ($0.16), with a volume of 1368061 shares changing hands. The stock had previously closed at GBX 12.88 ($0.17).

Creo Medical Group Trading Down 4.4 %

The firm has a market capitalization of £49.77 million, a price-to-earnings ratio of -1.95 and a beta of 0.86. The business’s 50-day moving average price is GBX 16.11 and its 200 day moving average price is GBX 18.97. The company has a debt-to-equity ratio of 29.96, a current ratio of 3.24 and a quick ratio of 2.19.

Insiders Place Their Bets

In other Creo Medical Group news, insider Richard John Rees bought 4,712 shares of Creo Medical Group stock in a transaction dated Thursday, January 16th. The stock was bought at an average cost of GBX 19 ($0.24) per share, for a total transaction of £895.28 ($1,152.67). 22.43% of the stock is currently owned by company insiders.

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.